BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.450
-0.010 (-0.68%)
May 16, 2025, 10:21 AM - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $7.93 million as of May 16, 2025. Its market cap has decreased by -91.70% in one year.
Market Cap
7.93M
Enterprise Value
82.50M
1-Year Change
-91.70%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $7.93M, a decrease of -95.41%. That is a compound annual growth rate of -34.85%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |